EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Conversational AI Phone Calls to Support Patients With Atrial Fibrillation: Randomized Controlled Trial

Ritu Trivedi, Liliana Laranjo, Simone Marschner, Aravinda Thiagalingam, Stuart Thomas, Saurabh Kumar, Tim Shaw, Clara K Chow

JMIR Cardio · 19.08.2025 · 9 · e64326-e64326

DOI: 10.2196/64326 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Cardio, online erschienen am 19.08.2025. Verfasst von Ritu Trivedi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Level 5, Block K, Westmead Hospital, Hawkesbury Road, Wes…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Quality of Life, Artificial Intelligence, Self-Management. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patient education and self-management support are critical for atrial fibrillation (AF) management. Conversational artificial intelligence (AI) has the potential to provide interactive and personalized support, but has not been evaluated in patients with AF.

Objective

This study aimed to evaluate the feasibility of a conversational AI intervention to support patients with AF postdischarge.

Methods

This was a single-blinded, 4:1-parallel–randomized controlled trial with process evaluation of feasibility and engagement. The primary outcome was the change in Atrial Fibrillation Effect on Quality-of-Life (AFEQT) questionnaire total score between groups. Patients with AF (18 y and older) were recruited postdischarge from Westmead Hospital cardiology services and randomized to receive either the intervention or usual care. The 6-month intervention consisted of fully automated conversational AI phone calls (with speech recognition and natural language processing) that regularly assessed patient health and symptoms and provided self-management support and education. These phone calls were supplemented with an online survey (sent via text message or email) containing replicated call content when participants could not be reached after 3 call attempts. If participant responses were concerning (eg, poor overall health, low medication confidence, and high symptom burden), they would be followed up with an ad hoc phone call and directed to clinical care if required. A semipersonalized education website was also available as part of the intervention, and participants were encouraged weekly (nudges delivered via text messages or emails) to visit it.

Results

A total of 103 patients (mean age, 63.7 y, SD 11.2 y; n=72, 70% male) were randomized (82 to the intervention); the target sample size was 385. The difference in the AFEQT total score was nonsignificant (adjusted mean difference 2.08, 95% CI −7.79 to 11.96; P =.46). An exploratory prepost comparison revealed an improvement in total AFEQT score in the intervention group only (baseline: 69.9, 95% CI 64.4 to 75.5; 6 months: 79.9, 95% CI 74.9 to 84.8; P =.01). Participants completed 4 of 7 outreaches on average, and 88.4% (304/344) of completed outreaches were reported as useful.

Conclusions

This proof-of-concept study demonstrates the feasibility of conversational AI in supporting patients with chronic conditions postdischarge. Intervention participants had improvement in their atrial fibrillation quality of life, though the forced shortening of the evaluation was unable to demonstrate a significant difference between groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationQuality of LifeArtificial IntelligenceSelf-ManagementPatient Education as TopicTelephoneHumansMaleFemaleAgedMiddle AgedSingle-Blind MethodSurveys and QuestionnairesFeasibility Studies

Stichwörter der Autor:innen

atrial fibrillationconversational artificial intelligencedigital healthfeasibilitynatural language processingphone callsquality of liferandomized controlled trialself-management

Autor:innen und Institutionen

  • Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney, Level 5, Block K, Westmead Hospital, Hawkesbury Road, Westmead, 2145, Australia, 61 2 8890 3125.
  • Cardiology Department, Westmead Hospital, Westmead, Australia.
  • Charles Perkins Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.

Zitieren

APA

Trivedi, R., Laranjo, L., Marschner, S., Thiagalingam, A., Thomas, S., Kumar, S., Shaw, T., & Chow, C. K. (2025). Conversational AI Phone Calls to Support Patients With Atrial Fibrillation: Randomized Controlled Trial. JMIR Cardio, 9, e64326-e64326. https://doi.org/10.2196/64326

Vancouver

Trivedi R, Laranjo L, Marschner S, Thiagalingam A, Thomas S, Kumar S, et al. Conversational AI Phone Calls to Support Patients With Atrial Fibrillation: Randomized Controlled Trial. JMIR Cardio. 2025;9:e64326-e64326. doi:10.2196/64326

BibTeX
@article{Trivedi2025,
  author = {Trivedi, Ritu and Laranjo, Liliana and Marschner, Simone and Thiagalingam, Aravinda and Thomas, Stuart and Kumar, Saurabh and Shaw, Tim and Chow, Clara K},
  title = {Conversational AI Phone Calls to Support Patients With Atrial Fibrillation: Randomized Controlled Trial},
  journal = {JMIR Cardio},
  year = {2025},
  volume = {9},
  pages = {e64326--e64326},
  doi = {10.2196/64326}
}
Kostenlos starten →